B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer

被引:87
|
作者
Liu, Yu [1 ]
Zeng, Bin [1 ]
Zhang, Zhuohan [1 ]
Zhang, Yuan [1 ]
Yang, Rongcun [1 ]
机构
[1] Nankai Univ, Sch Med, Dept Immunol, Tianjin 300071, Peoples R China
关键词
Myeloid-derived suppressor cells; B7-H1; Immune suppression;
D O I
10.1016/j.clim.2008.07.030
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Myeloid-derived suppressor cells (MDSCs) accumulate in tumor-bearing hosts and are associated with immune suppression. Here, we described high level of expression of B7-H1 (CD274), PD-1 (CD279) and CTLA4 (CD152) by Gr-1(+)CD11b(+) MDSCs obtained from both ascites and spleens of mice bearing the 1D8 ovarian carcinoma, whereas B7-DC (CD273), CD40 and CD86 were absent. In contrast, B7-H1, PD-1 and CTLA-4 expression was not detected on Gr-1(+)CD11b(+) cells from naive mice. Expression of B7-H1 by Gr-1(+)CD11b(+) cells from naive mice could be induced by co-culture with 1D8 ovarian carcinoma cells. Gr-1(+)CD11b(+) cells derived from 1D8 tumor-bearing mice markedly suppressed antigen-specific immune responses, whereas Gr-1(+)CD11b(+) cells from naive mice did not. siRNA-mediated knockdown of B7-H1 in Gr-1(+)CD11b(+) cells of 1D8 tumor-bearing mice alleviated suppression of antigen-specific immune responses. Suppression of antigen-specific immune responses via B7-H1 on Gr-1(+)CD11b(+) myeloid cells was mediated by CD4(+)CD25(+) Foxp3(+) T regulatory cells and required PD-1. Antibody blockade of either B7-H1 or PD-1 retarded the growth of 1D8 tumor in mice. This suggests that expression of B7-H1 on Gr-1(+)CD11b(+) myeloid cells triggered by the 1D8 mouse model of ovarian carcinoma suppresses antigen-specific immunity via interaction with PD-1 on CD4(+)CD25(+) Foxp3(+) regulatory T cells. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:471 / 481
页数:11
相关论文
共 50 条
  • [31] Myeloid-derived suppressor cells in breast cancer
    Markowitz, Joseph
    Wesolowski, Robert
    Papenfuss, Tracey
    Brooks, Taylor R.
    Carson, William E., III
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 140 (01) : 13 - 21
  • [32] Myeloid-Derived Suppressor Cells in Human Cancer
    Nagaraj, Srinivas
    Gabrilovich, Dmitry I.
    CANCER JOURNAL, 2010, 16 (04): : 348 - 353
  • [33] Curdlan blocks the immune suppression by myeloid-derived suppressor cells and reduces tumor burden
    Ke Rui
    Jie Tian
    Xinyi Tang
    Jie Ma
    Ping Xu
    Xinyu Tian
    Yungang Wang
    Huaxi Xu
    Liwei Lu
    Shengjun Wang
    Immunologic Research, 2016, 64 : 931 - 939
  • [34] The Dawn of Myeloid-Derived Suppressor Cells: Identification of Arginase I as the Mechanism of Immune Suppression
    Gabrilovich, Dmitry I.
    CANCER RESEARCH, 2021, 81 (15) : 3953 - 3955
  • [35] Plasticity of myeloid-derived suppressor cells in cancer
    Tcyganov, Evgenii
    Mastio, Jerome
    Chen, Eric
    Gabrilovich, Dmitry I.
    CURRENT OPINION IN IMMUNOLOGY, 2018, 51 : 76 - 82
  • [36] Myeloid-derived suppressor cells in transplantation and cancer
    Jordi C. Ochando
    Shu Hsia Chen
    Immunologic Research, 2012, 54 : 275 - 285
  • [37] Hepatic myeloid-derived suppressor cells in cancer
    Medina-Echeverz, Jose
    Eggert, Tobias
    Han, Miaojun
    Greten, Tim F.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (08) : 931 - 940
  • [38] Curdlan blocks the immune suppression by myeloid-derived suppressor cells and reduces tumor burden
    Rui, Ke
    Tian, Jie
    Tang, Xinyi
    Ma, Jie
    Xu, Ping
    Tian, Xinyu
    Wang, Yungang
    Xu, Huaxi
    Lu, Liwei
    Wang, Shengjun
    IMMUNOLOGIC RESEARCH, 2016, 64 (04) : 931 - 939
  • [39] Potential Novel Ovarian Cancer Treatment Targeting Myeloid-Derived Suppressor Cells
    Abiko, Kaoru
    Hayashi, Takuma
    Yamaguchi, Ken
    Mandai, Masaki
    Konishi, Ikuo
    CANCER INVESTIGATION, 2021, 39 (04) : 310 - 314
  • [40] Depletion of immunosuppressive myeloid-derived suppressor cells impedes ovarian cancer growth
    Rattan, R.
    Dar, S.
    Rasool, N.
    Ali-Fehmi, R.
    Giri, S.
    Munkarah, A. R.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 213 - 214